Bain Capital Venture Investors LLC Takes $18.13 Billion Position in Waystar Holding Corp. $WAY

Bain Capital Venture Investors LLC purchased a new position in Waystar Holding Corp. (NASDAQ:WAY - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 882,965 shares of the company's stock, valued at approximately $18,127,271,000. Waystar comprises about 13.6% of Bain Capital Venture Investors LLC's holdings, making the stock its 2nd biggest position. Bain Capital Venture Investors LLC owned 0.46% of Waystar at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Clarkston Capital Partners LLC purchased a new stake in shares of Waystar during the 1st quarter valued at $22,917,000. Hsbc Holdings PLC purchased a new position in Waystar in the first quarter worth $5,625,000. Diamond Hill Capital Management LLC Investment Advisor purchased a new position in Waystar in the second quarter worth $43,314,000. Perigon Wealth Management LLC bought a new position in Waystar in the second quarter valued at $878,000. Finally, Aurora Investment Counsel bought a new position in Waystar in the second quarter valued at $1,765,000.

Waystar News Summary

Here are the key news stories impacting Waystar this week:

• Positive Sentiment: Waystar launched new AltitudeAI agentic capabilities designed to autonomously execute revenue-cycle tasks, including claims processing, denial management, documentation, and patient billing. The company says the tools connect AI-generated insights directly to action, potentially improving provider efficiency and strengthening long-term revenue growth. Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
• Positive Sentiment: Coverage of the product rollout highlights Waystar’s expansion of AI-powered tools across claims, denials, and revenue-cycle documentation. Successful adoption could increase customer value, support pricing power, and differentiate Waystar in healthcare payment software. Waystar expands AI-powered agentic revenue cycle tools
• Positive Sentiment: Needham reaffirmed its Buy rating and set a $33 price target, implying substantial upside from the referenced stock level. The endorsement may reinforce investor confidence in Waystar’s growth and AI strategy. Needham rating report
• Positive Sentiment: Waystar announced two executive leadership appointments intended to accelerate innovation, client adoption, and durable growth, adding support to management’s autonomous-revenue-cycle strategy. Waystar Expands Executive Leadership to Accelerate Innovation and Growth
• Neutral Sentiment: Waystar’s analyst/investor-day transcript and presentation provide additional detail on its strategy, but the supplied reports do not identify specific new financial guidance or targets. Waystar Analyst/Investor Day Transcript
• Neutral Sentiment: Reported short-interest data showed zero shares and a zero-day ratio, but the figures include an invalid percentage-change calculation and appear unreliable, offering little usable signal for investors.

Insider Buying and Selling at Waystar

In related news, CEO Matthew J. Hawkins sold 60,038 shares of the company's stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $25.01, for a total transaction of $1,501,550.38. Following the completion of the transaction, the chief executive officer owned 1,835,081 shares in the company, valued at $45,895,375.81. This represents a 3.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 3.50% of the company's stock.

Waystar Stock Down 0.2%

Shares of Waystar stock opened at $24.17 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85. Waystar Holding Corp. has a 52-week low of $17.26 and a 52-week high of $41.47. The stock has a market capitalization of $4.63 billion, a price-to-earnings ratio of 34.53, a P/E/G ratio of 0.94 and a beta of 0.06. The company's 50 day moving average price is $22.58 and its 200-day moving average price is $22.66.

Waystar (NASDAQ:WAY - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. The company had revenue of $319.67 million during the quarter, compared to analyst estimates of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The firm's revenue was up 18.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.36 EPS. Equities research analysts forecast that Waystar Holding Corp. will post 1.47 EPS for the current year.

Analyst Upgrades and Downgrades

WAY has been the subject of several research analyst reports. KeyCorp reaffirmed an "overweight" rating on shares of Waystar in a research note on Friday, July 31st. JPMorgan Chase & Co. reduced their price objective on Waystar from $40.00 to $38.00 and set an "overweight" rating on the stock in a research report on Thursday, April 30th. Raymond James Financial reissued a "strong-buy" rating and set a $32.00 price objective on shares of Waystar in a report on Thursday, April 30th. Citigroup restated a "buy" rating on shares of Waystar in a research report on Monday, July 20th. Finally, Weiss Ratings lowered Waystar from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Wednesday, June 24th. Three investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Waystar has a consensus rating of "Moderate Buy" and an average target price of $35.00.

About Waystar

Waystar NASDAQ: WAY is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company's unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar's offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source